The degree of sputum eosinophil suppression by generic SFC was not inferior to original SFC , and this was not affected by treatments with the sequence of generic SFC first vs. original SFC second or original SFC first vs. generic SFC. In addition , there was no significant difference between treatments in terms of normalized gain in asthma control scores , including the number of patients found to have improved asthma control , irrespective of sequence , as change from baseline .